04:32 PM EDT, 08/26/2024 (MT Newswires) -- Douglas Forsyth, Director, on August 22, 2024, executed a purchase for 75,000 shares in Inhibrx Biosciences ( INBX ) for $1,037,328. Following the Form 4 filing with the SEC, Forsyth has control over a total of 224,564 shares of the company, with 224,564 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2007919/000200791924000040/xslF345X05/wk-form4_1724704006.xml

Price: 14.05, Change: +0.12, Percent Change: +0.86